PT993447E - Processo para a preparacao de benzenossulfonato de amlodipina - Google Patents

Processo para a preparacao de benzenossulfonato de amlodipina

Info

Publication number
PT993447E
PT993447E PT99912189T PT99912189T PT993447E PT 993447 E PT993447 E PT 993447E PT 99912189 T PT99912189 T PT 99912189T PT 99912189 T PT99912189 T PT 99912189T PT 993447 E PT993447 E PT 993447E
Authority
PT
Portugal
Prior art keywords
amlodipine
preparation
benzenesulphonate
benzenosulfonate
medicament
Prior art date
Application number
PT99912189T
Other languages
English (en)
Inventor
Wlostowski Marek
Wieczorek Maciej
Original Assignee
Adamed Sp Zoo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20071938&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT993447(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Adamed Sp Zoo filed Critical Adamed Sp Zoo
Publication of PT993447E publication Critical patent/PT993447E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PT99912189T 1998-04-09 1999-04-08 Processo para a preparacao de benzenossulfonato de amlodipina PT993447E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL98325757A PL189666B1 (pl) 1998-04-09 1998-04-09 Sposób otrzymywania benzenosulfonianu amlodypiny

Publications (1)

Publication Number Publication Date
PT993447E true PT993447E (pt) 2005-10-31

Family

ID=20071938

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99912189T PT993447E (pt) 1998-04-09 1999-04-08 Processo para a preparacao de benzenossulfonato de amlodipina

Country Status (15)

Country Link
EP (1) EP0993447B1 (pt)
KR (1) KR100323244B1 (pt)
CN (1) CN1122023C (pt)
AT (1) ATE302187T1 (pt)
AU (1) AU3061399A (pt)
CZ (1) CZ295311B6 (pt)
DE (1) DE69926704D1 (pt)
ES (1) ES2245823T3 (pt)
HU (1) HUP0003300A3 (pt)
PL (1) PL189666B1 (pt)
PT (1) PT993447E (pt)
RU (1) RU2177000C2 (pt)
SK (1) SK282736B6 (pt)
UA (1) UA57091C2 (pt)
WO (1) WO1999052873A1 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT5874U1 (de) 2000-12-29 2003-01-27 Bioorg Bv Pharmazeutische zubereitungen enthaltend amlodipinmaleat
MXPA03005886A (es) 2000-12-29 2005-04-19 Pfizer Ltd Derivado de aspartato de amlodipina como antagonista del canal de calcio.
US6653481B2 (en) 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine
CA2433193C (en) 2000-12-29 2006-01-31 Pfizer Limited Amide derivative of amlodipine
US7335380B2 (en) 2000-12-29 2008-02-26 Synthon Ip Inc. Amlodipine free base
RS53403A (en) 2000-12-29 2006-10-27 Pfizer Limited Process for making amlodipine maleate
EA008141B1 (ru) * 2000-12-29 2007-04-27 Пфайзер Лимитед Способ получения малеата амлодипина
WO2002053539A1 (en) 2000-12-29 2002-07-11 Pfizer Limited Amlodipine hemimaleate
WO2002054062A2 (en) 2000-12-29 2002-07-11 Pfizer Limited Reference standards and processes for determining the purity or stability of amlodipine maleate
MXPA03005882A (es) 2000-12-29 2005-04-19 Pfizer Ltd Derivado amida de amlodipina.
CA2433181C (en) 2000-12-29 2005-11-22 Pfizer Limited Amlodipine hemifumarate
EP1221438B1 (de) * 2001-01-09 2007-03-14 Siegfried Generics International AG Salze von Amlodipin-Mesylat
DE60235101D1 (de) 2001-07-06 2010-03-04 Lek Pharmaceuticals Verfahren zur herstellung hochreines amlodipinbenzolsulfonat
US6680334B2 (en) 2001-08-28 2004-01-20 Pfizer Inc Crystalline material
US6828339B2 (en) * 2001-11-21 2004-12-07 Synthon Bv Amlodipine salt forms and processes for preparing them
KR100462304B1 (ko) 2002-07-30 2004-12-17 씨제이 주식회사 암로디핀의 유기산염
KR100496436B1 (ko) 2002-07-30 2005-06-20 씨제이 주식회사 암로디핀의 유기산염
KR100538641B1 (ko) 2002-07-30 2005-12-22 씨제이 주식회사 암로디핀의 유기산염
KR100467669B1 (ko) * 2002-08-21 2005-01-24 씨제이 주식회사 암로디핀의 유기산염
US6784297B2 (en) 2002-09-04 2004-08-31 Kopran Limited Process for the preparation of anti-ischemic and anti-hypertensive drug amlodipine besylate
AU2003253460A1 (en) * 2002-09-19 2004-04-08 Cj Corporation Crystalline organic acid salt of amlodipine
WO2005089353A2 (en) * 2004-03-16 2005-09-29 Sepracor Inc. (s)-amlodipine malate
CN100391946C (zh) * 2006-05-26 2008-06-04 苏州东瑞制药有限公司 一种苯磺酸氨氯地平的制备方法
PL236001B1 (pl) 2012-12-21 2020-11-30 Adamed Spolka Z Ograniczona Odpowiedzialnoscia Złożona kompozycja farmaceutyczna zawierająca kandesartan cyleksetylu oraz amlodypinę, sposób jej wytwarzania oraz jednostkowa postać dawkowania zawierająca tę kompozycję
CN103044314A (zh) * 2013-01-06 2013-04-17 先声药业有限公司 马来酸氨氯地平的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608335D0 (en) * 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts

Also Published As

Publication number Publication date
ES2245823T3 (es) 2006-01-16
PL189666B1 (pl) 2005-09-30
DE69926704D1 (de) 2005-09-22
KR100323244B1 (ko) 2002-02-19
ATE302187T1 (de) 2005-09-15
CN1263525A (zh) 2000-08-16
HUP0003300A2 (en) 2001-03-28
KR20010013297A (ko) 2001-02-26
SK282736B6 (sk) 2002-11-06
EP0993447B1 (en) 2005-08-17
AU3061399A (en) 1999-11-01
UA57091C2 (uk) 2003-06-16
HUP0003300A3 (en) 2002-11-28
CN1122023C (zh) 2003-09-24
WO1999052873A1 (en) 1999-10-21
EP0993447A1 (en) 2000-04-19
CZ466999A3 (cs) 2000-04-12
RU2177000C2 (ru) 2001-12-20
PL325757A1 (en) 1999-10-11
CZ295311B6 (cs) 2005-07-13
SK169899A3 (en) 2000-06-12

Similar Documents

Publication Publication Date Title
PT993447E (pt) Processo para a preparacao de benzenossulfonato de amlodipina
ATE266634T1 (de) Cyclobutyl-aryloxysulfonylamin- hydroxamsäurederivate
MY120235A (en) Aryloxyarylsulfonylamino hydroxamic acid derivatives
PT977741E (pt) Derivados de fenilo substituido, sua preparacao e utilizacao
NO20063572L (no) Kinazolinditosylatsalt forbindelser
WO2001066564A3 (en) Gamma-secretase inhibitors
DE60218688D1 (de) Elektrodialyse von mehrwertigen metallsalzen
ES2151156T3 (es) Derivados de acidos n-(aroil)glicina hidroxamicos y compuestos relacionados.
LV12585A (en) Sustained-release preparation for all antagonist production and use thereof
HUT44937A (en) Process for producing pharmaceuticals comprising dipyridamole or mopidamole and o-acetyl-salicylic acid, resp. the salts thereof
ES2191208T3 (es) Oxiimino-pregnano-carbolactonas.
NO20002440L (no) Hydroksam- og karboksylsyrederivater med MMP- og TNF- inhiberende aktivitet
ES2053439T3 (es) Un procedimiento para la preparacion de un compuesto que tiene propiedades farmacologicas utiles.
AR016694A1 (es) Procedimiento para la preparacion de derivados de acidos 8-metoxi-3-quinoloncarboxilicos y procedimiento de purificacion.
DE60002769D1 (de) Wasserhaltiges, kristallines Calcium-Salz der Simvastatin Dihydroxy offene Säure
HUP9904030A2 (hu) Tiagabin felhasználása pszichotikus rendellenességek kezelésére alkalmas gyógyszer előállítására
ES2172968T3 (es) Procedimiento para la obtencion de creatina o de monohidrato de creatina.
WO2002098843A3 (en) Certain salts of discodermolide acid, pharmaceutical compositions containing them and their use in treating tumors
ES2195378T3 (es) Procedimiento para la sintesis de taxanos.
EA200100317A1 (ru) Новые производные бензоилгуанидина с эффективными свойствами, способ их получения и их применение при изготовлении лекарственных средств
DE60111634D1 (de) Verfahren zur herstellung von thiazolidinedion-derivaten und zwischenprodukte
FR2784582B3 (fr) Nouvelle utilisation therapeutique de composes a activite beta-3-agoniste
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
HUP0401617A3 (en) Process for the preparation of (r)- or (s)-aminocarnitine inner salt, the salts and derivatives thereof
DK0677513T3 (da) Octahydro-2-naphthalencarboxylsyrederivat, dets fremstilling og anvendelse